Centre Hospitalier Intercommunal Creteil

At Centre Hospitalier Intercommunal Creteil, clinical trial activity is focused on cancer research, with a strong emphasis on treatments for extensive stage small cell lung cancer. The studies are designed to evaluate whether new treatment approaches can improve patient outcomes and extend survival in this difficult-to-treat disease.

• Research on extensive stage small cell lung cancer in the first-line setting
• Evaluation of tarlatamab combined with durvalumab versus durvalumab alone
• Focus on improving overall survival and treatment effectiveness in advanced lung cancer

This medical oncology program reflects a targeted effort to advance care for aggressive neoplasms through studies that compare new therapeutic strategies with current standard treatment.